Reuters

On Monday, the Nobel Prize committee at the Karolinska Institute in Stockholm, Sweden, awarded US scientists Victor Ambros and Gary Ruvkun the 2024 Nobel Prize in Medicine for discovering microRNA and its essential role in the growth and survival of multicellular organisms.

ABC News

Ambros and Ruvkun originally studied genes that regulate genetic development. The panel concluded that their study "revealed a new dimension to gene regulation, essential for all complex life forms."

Al Jazeera

Ruvkun conducted his research at Massachusetts General Hospital and Harvard Medical School, where he currently teaches genetics. Ambros undertook his research at Harvard and is also now a professor at the University of Massachusetts Chan Medical School.

NobelPrize.org

The Nobel Committee for Physiology or Medicine issued a statement outlining the two researchers' contributions and framed the importance of the discovery — stating that because all human cells have the same chromosomes, they share the same genes and set of instructions.

Guardian

Olle Kämpe, vice chair committee, remarked, "The seminal discovery of microRNA has introduced a new and unexpected mechanism of gene regulation," with implications for advancing knowledge about diseases such as cancer.

France 24

Ambros and Ruvkun will share a cash award of 11M Swedish kronor ($1M) awarded to them at a ceremony in Stockholm on Dec. 10, the anniversary of Alfred Nobel's death.

Reuters #

On Monday, the Nobel Prize committee at the Karolinska Institute in Stockholm, Sweden, awarded US scientists Victor Ambros and Gary Ruvkun the 2024 Nobel Prize in Medicine for discovering microRNA and its essential role in multicellular organism growth and survival.

Al Jazeera #

CNN #

The Nobel committee issued a statement outlining the two researchers' contributions and stated that, because all cells have the same chromosomes, they all have the exact same genes and set of instructions.

Guardian #

Olle Kämpe, vice chair of the Nobel committee for Physiology or Medicine, remarked, "The seminal discovery of microRNA has introduced a new and unexpected mechanism of gene regulation." MicroRNAs help us comprehend embryology, cell physiology, and cancer, he explained.

France24

Ambros and Ruvkun will share a cash award of 11M Swedish kronor ($1M) awarded to them at a ceremony in Stockholm on December 10, the anniversary of Alfred Nobel's death.

Victor Ambros and Gary Ruvkun's remarkable discovery of microRNA earned them this year's Nobel Prize in Medicine. They found a new class of small RNA molecules that play an important function in gene regulation. The two scientists have uncovered a new level of understanding in the development and function of multicellular organisms, including humans.

Press release: The Nobel Prize in Physiology or Medicine 2024

The recognition of microRNAs with the 2024 Nobel Prize in Medicine was an unexpected yet welcome development for some researchers, given that microRNA therapies remain in their early stages. The Nobel Committee awarded the Medicine Prize in 2006 for the discovery of small interfering RNAs, which control genes through an alternative mechanism, following the identification of microRNAs. Researchers hope to eventually use these master regulators for disease detection and treatment.

Nature

Medicine Nobel awarded for gene-regulating microRNAs

Atila Altuntas/Contributor/Anadolu via Getty Images

US Duo Wins Nobel Prize for MicroRNA Discovery

Sweden

Medicine & healthcare

Research

Victor Ambros and Gary Ruvkun's remarkable discovery of microRNA earned them this year's Nobel Prize in Medicine. The two scientists have uncovered a new level of understanding in the development and function of multicellular organisms, including humans, with the potential to help further research about cancer and other diseases.

While there are multiple microRNA studies aimed at treating cancer and other diseases, any potential applications are far away. This discovery is an important step, but as cancer rates continue to rise, the best approach is to focus on disease prevention strategies. Regrettably, treatment alone will never be enough.

Harvard Public Health Magazine

The Cancer Miracle Isn’t a Cure. It’s Prevention.

Axios

Nobel Prize Medicine 2024 Microrna Ambros Ruvku

There's a 50% chance that there will be a breakthrough in the treatment of hard-to-treat cancers by at least the timeframe 2031-2036.

Metaculus

When will there be a breakthrough in the treatment of hard-to-treat cancers?

Videos

Apps

US Duo Wins Nobel Prize for MicroRNA Discovery

US Duo Wins Nobel Prize for MicroRNA Discovery

The Facts

The Spin

Metaculus Prediction

Sign up to our daily newsletter